BTC falls below 46000 US dollars

Updated version 1 - The U.S. Food and Drug Administration (FDA) has approved Inovio's drug for treating a rare throat disease; the company's stock price surged.

Updated Version 2 - US FDA approves Inovio's therapy for rare respiratory disease; stock price surges

Creatd's Letter of Intent to Acquire Remaining C2 Capital Stake Expires Without Deal

Frontier Nuclear & Minerals delays annual report as financial statements, audit remain unfinished